1. PWE-025 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients with Irritable Bowel Syndrome with Constipation (IBS-C): Pooled Analysis of 2 Phase 3 Trials. (4th June 2013) Authors: Rao, S S; Chang, L; Hao, X; Lavins, B; Shiff, S J; Cao, X; Schneier, H; Currie, M; Johnston, J Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-026 Effects of 26 Weeks of Linaclotide Treatment on Adequate Relief and IBS Severity in Patients with Irritable Bowel Syndrome with Constipation (IBS-C). (4th June 2013) Authors: Quigley, E M; Chey, W D; Lavins, B; Baird, M; Fitch, D; Hao, X; Shi, K; Currie, M; Schneier, H; Johnston, J Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-028 Significantly Improved Abdominal Pain (AP) with Linaclotide (LIN) vs Placebo (PBO) in Patients (PTS) with Irritable Bowel Syndrome (IBS) Regardless of Baseline Pain Severity in 2 Phase 3 Trials. (4th June 2013) Authors: Johnston, J; Chey, W D; Lavins, B; Shiff, S J; Kurtz, C; MacDougall, J; Jia, X; Schneier, H; Currie, M Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-029 Characterisation and Association of Abdominal Pain With Anxiety or Depression in Patients with Irritable Bowel Syndrome with Constipation (IBS-C). (4th June 2013) Authors: Quigley, E M; Lavins, B; Shiff, S J; Shi, K; Hao, X; Kurtz, C; Currie, M; Schneier, H; Johnston, J Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗